The Study of Women's Health Across the Nation (SWAN): The Impact of Midlife and the Menopause Transition on Health and Functioning in Early Old Age
全国妇女健康研究 (SWAN):中年和更年期过渡对早年健康和功能的影响
基本信息
- 批准号:10292495
- 负责人:
- 金额:$ 19.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-30 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAddressAdministrative SupplementAgeAgingAmericanAnxietyBehaviorBiologyBlood GlucoseBlood PressureBusinessesCOVID-19COVID-19 mortalityCOVID-19 pandemicCardiovascular systemCaringChronic DiseaseDataDiabetes MellitusEconomicsEnrollmentEthnic OriginEventFrightGoalsHealthHealth behaviorHealth care facilityHomeHospitalizationImpaired cognitionInfectionLinkLipidsLocationMasksMeasuresMedicalMenopauseMental DepressionMental HealthNeighborhoodsObesityOccupationsOutcomeParticipantPersonal SatisfactionPersonsPhysical FunctionPopulationPopulation DensityPreventive careProviderRaceRiskRisk FactorsSARS-CoV-2 infectionSecuritySerologySocial DistanceSocial isolationSocial supportSocioeconomic StatusStressStudy of Women&aposs Health Across the NationSymptomsTimeUnited StatesVirusVisitWell in selfWomanbone healthcardiometabolismcardiovascular healthcognitive functioncohortdesignexperiencefollow-uphealth care availabilityhealth care service utilizationhealth related quality of lifehigh riskhuman old age (65+)interestlow socioeconomic statusmiddle agemulti-racialoptimismpandemic diseasephysical conditioningprospectiveprotective factorspsychologicracial and ethnicresilienceresponsescreeningseropositivesleep healthsocialsocial engagementsymptomatic COVID-19urgent care
项目摘要
The Study of Women's Health Across the Nation (SWAN): The Impact of Midlife and the Menopause
Transition on Health and Functioning in Early Old Age. Administrative Supplement
ABSTRACT
The Coronavirus Disease 2019 (COVID-19) pandemic, has dramatically changed the way we live and interact.
In addition to claiming more than 220,000 lives and infecting more than 8 million people in the United States
(US) to date, many more millions have suffered economically through job or business loss; suffered from social
isolation, anxiety or depression; and have not received or delayed medical care. This administrative
supplement to SWAN-Aging: The Impact of Midlife and the Menopause Transition on Health and Functioning in
Early Old Age (1U19AG063720-01A1) is in response to the Notice of Special Interest NOT-AG-20-022: NIA
Availability of Administrative Supplements and Revision Supplements on COVID-19. The pandemic is
especially pertinent to SWAN-Aging participants as they are a high-risk, and potentially high-exposure,
population given their age and residential locations. The Study of Women’s Health Across the Nation (SWAN)
is a multi-racial/ethnic cohort of women, enrolled at age 42-52 and followed for over 25 years with longitudinal
measures of economic strain and stress, health behaviors, cognitive and physical functioning, and mental and
physical health. SWAN-Aging will prospectively link comprehensive longitudinal characterization of the
menopause transition (MT) and midlife health indicators to functioning and multiple health domains in early old
age (65-75 years), including cognitive impairment and cognitive decline, physical functioning, psychological
well-being, sleep, and cardiovascular and bone health. A follow-up visit, planned to start July 2021, provides a
unique opportunity to evaluate the longer-term impact of the pandemic on women’s economic security, access
to health care, their cognitive and physical functioning, and physical and mental health in early old age. SWAN-
Aging’s overall goal is to enhance understanding of successful aging in women. Without collecting time-
sensitive data on COVID-19 infection and its consequences, SWAN-Aging will not be able to account for the
impact of the pandemic on participants’ health and well-being. This administrative supplement is designed to
evaluate the effect of infection and symptoms, social and economic disruption, and delayed medical care on
multiple aspects of health and functioning in early old age. The wealth of previously collected longitudinal data
will allow us to a) account for person-specific, pre-pandemic trajectories of biology, functioning, and health,
when disentangling the causal impact of the COVID-19 pandemic from aging, and b) delineate risk and
protective factors for pandemic-related effects on health and functioning. Its goals are 1) to characterize
COVID-19 infection (seropositivity, symptoms, and hospitalizations) and determine longer-term effects of the
pandemic on health and functioning in SWAN-Aging women; 2) to determine the effect of the pandemic and
mitigation efforts on economic security, social engagement, health behaviors, and health and functioning
outcomes; and 3) to determine the effect of COVID-19-related delays in receiving medical care on health.
全国妇女健康研究 (SWAN):中年和更年期的影响
早年健康和功能的转变。行政补充
抽象的
2019 年冠状病毒病 (COVID-19) 大流行极大地改变了我们的生活和互动方式。
除了在美国夺走了超过22万人的生命并感染了超过800万人
(美国)迄今为止,还有数百万人因失业或生意损失而遭受经济损失;遭受社会
孤立、焦虑或抑郁;并且没有接受或延误医疗护理。本次行政
SWAN-Aging 的补充:中年和更年期过渡对健康和功能的影响
早年 (1U19AG063720-01A1) 是对特殊利益通知 NOT-AG-20-022 的回应:NIA
有关 COVID-19 的行政补充和修订补充的可用性。此次疫情是
尤其与 SWAN-Aging 参与者相关,因为他们是高风险且潜在的高暴露人群,
考虑到年龄和居住地点的人口。全国妇女健康研究 (SWAN)
是一个多种族/民族的女性队列,在 42-52 岁之间入组,并进行了超过 25 年的纵向跟踪研究。
经济紧张和压力、健康行为、认知和身体功能以及精神和心理方面的衡量标准
身体健康。 SWAN-Aging 将前瞻性地将综合纵向特征联系起来
更年期过渡 (MT) 和中年健康指标对早期老年人的功能和多个健康领域的影响
年龄(65-75岁),包括认知障碍和认知衰退、身体机能、心理
健康、睡眠、心血管和骨骼健康。计划于 2021 年 7 月开始的后续访问提供了
评估这一流行病对妇女经济安全、获得机会的长期影响的独特机会
保健、他们的认知和身体功能以及早年的身心健康。天鹅-
《老龄化》的总体目标是增强女性对成功老龄化的理解。无需收集时间——
有关 COVID-19 感染及其后果的敏感数据,SWAN-Aging 将无法解释
大流行对参与者健康和福祉的影响。本行政补充的目的是
评估感染和症状、社会和经济混乱以及医疗护理延迟对患者的影响
早年健康和功能的多个方面。先前收集的大量纵向数据
将使我们能够a)解释特定于个人的、大流行前的生物学、功能和健康轨迹,
在理清 COVID-19 大流行与老龄化之间的因果影响时,b) 描述风险和
大流行相关的健康和功能影响的保护因素。其目标是 1) 表征
COVID-19 感染(血清阳性、症状和住院治疗)并确定其长期影响
流行病对 SWAN 老年妇女健康和功能的影响; 2)确定大流行的影响
经济安全、社会参与、健康行为以及健康和功能方面的缓解努力
结果; 3) 确定与 COVID-19 相关的延迟接受医疗服务对健康的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHERRI-ANN M BURNETT-BOWIE其他文献
SHERRI-ANN M BURNETT-BOWIE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHERRI-ANN M BURNETT-BOWIE', 18)}}的其他基金
The Study of Women's Health Across the Nation (SWAN): The Impact of Midlife and the Menopause Transition on Health and Functioning in Early Old Age
全国妇女健康研究 (SWAN):中年和更年期过渡对早年健康和功能的影响
- 批准号:
10263894 - 财政年份:2020
- 资助金额:
$ 19.67万 - 项目类别:
The Study of Women's Health Across the Nation (SWAN): The Impact of Midlife and the Menopause Transition on Health and Functioning in Early Old Age
全国妇女健康研究 (SWAN):中年和更年期过渡对早年健康和功能的影响
- 批准号:
10471452 - 财政年份:2020
- 资助金额:
$ 19.67万 - 项目类别:
The Study of Women's Health Across the Nation (SWAN): The Impact of Midlife and the Menopause Transition on Health and Functioning in Early Old Age
全国妇女健康研究 (SWAN):中年和更年期过渡对早年健康和功能的影响
- 批准号:
10447272 - 财政年份:2020
- 资助金额:
$ 19.67万 - 项目类别:
VITAMIN D DEFICIENCY: INSULIN RESISTANCE AND FGF-23
维生素 D 缺乏:胰岛素抵抗和 FGF-23
- 批准号:
7731274 - 财政年份:2008
- 资助金额:
$ 19.67万 - 项目类别:
Dietary and hormonal regulation of FGF-23 in humans
人类 FGF-23 的饮食和激素调节
- 批准号:
7433724 - 财政年份:2006
- 资助金额:
$ 19.67万 - 项目类别:
Dietary and hormonal regulation of FGF-23 in humans
人类 FGF-23 的饮食和激素调节
- 批准号:
7147855 - 财政年份:2006
- 资助金额:
$ 19.67万 - 项目类别:
VITAMIN D DEFICIENCY: INSULIN RESISTANCE AND FGF-23
维生素 D 缺乏:胰岛素抵抗和 FGF-23
- 批准号:
7607088 - 财政年份:2006
- 资助金额:
$ 19.67万 - 项目类别:
Dietary and hormonal regulation of FGF-23 in humans
人类 FGF-23 的饮食和激素调节
- 批准号:
7880829 - 财政年份:2006
- 资助金额:
$ 19.67万 - 项目类别:
Dietary and hormonal regulation of FGF-23 in humans
人类 FGF-23 的饮食和激素调节
- 批准号:
7647447 - 财政年份:2006
- 资助金额:
$ 19.67万 - 项目类别:
EFFECTS OF DIETARY PHOSPHATE ON THE REGULATION OF FGF-23
膳食磷酸盐对 FGF-23 调节的影响
- 批准号:
7205064 - 财政年份:2004
- 资助金额:
$ 19.67万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 19.67万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 19.67万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 19.67万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 19.67万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 19.67万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 19.67万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 19.67万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 19.67万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 19.67万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 19.67万 - 项目类别:
Research Grant














{{item.name}}会员




